Anne Li May 6th, 2017
Immunotherapies are changing the outlook for many cancer patients. Drugs that block cancer cells from deflecting an immune attack are now routinely used to treat advanced skin and kidney cancers, and are showing promise in other types of cancer too. But cancers are complex and diverse – what works well against one type of cancer might have little effect against another. The immunotherapies available for some patients aren’t a magic bullet that will work for everyone. So researchers all over the world are looking into other potential treatments that unleash the immune system against cancer, and one of these approaches uses genetic engineering to modify our immune cells. Professor John Anderson, a doctor and researcher who specialises in children’s cancers, tells us more about a Cancer Research UK clinical trial that he’s the leading doctor for.
See original article at: http://scienceblog.cancerresearchuk.org/2017/05/03/testing-a-new-immunotherapy-treatment-for-neuroblastoma/